SSG
BSX icon

Summit Securities Group’s Boston Scientific BSX Stock Holding History

Summit Securities Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Sell
344
-11,400
-97% -$619K ﹤0.01% 782
2026
Q1 		$737K Buy
11,744
+9,542
+433% +$763K 0.09% 118
2025
Q4 		$210K Sell
2,202
-352
-14% -$34.5K 0.03% 322
2025
Q3 		$249K Buy
2,554
+1,558
+156% +$161K 0.05% 243
2025
Q2 		$107K Buy
+996
New +$101K 0.02% 354
2023
Q3 		– Sell
-1,879
Closed -$102K – 603
2023
Q2 		$102K Sell
1,879
-933
-33% -$48.7K 0.01% 288
2023
Q1 		$141K Buy
2,812
+1,365
+94% +$64.3K 0.01% 249
2022
Q4 		$67K Buy
+1,447
New +$62.7K ﹤0.01% 660
2022
Q3 		– Sell
-2,991
Closed -$111K – 947
2022
Q2 		$111K Buy
2,991
+2,407
+412% +$98K 0.01% 395
2022
Q1 		$26K Buy
+584
New +$25.3K ﹤0.01% 676
2019
Q1 		– Sell
-14,116
Closed -$499K – 210
2018
Q4 		$499K Buy
+14,116
New +$512K 0.04% 199

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Summit Securities Group's BSX Position: Q2 2026 in Review

Summit Securities Group reduced its Boston Scientific (BSX) stake by 97% in Q2 2026, selling an estimated $619K and leaving 344 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #782.

Summit Securities Group first reported a position in BSX in Q4 2018 and has held it in 11 quarters since. The position peaked at $737K in Q1 2026. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Summit Securities Group held 344 shares of Boston Scientific worth $14.7K as of Q2 2026.
  • Summit Securities Group sold 11,400 Boston Scientific shares in Q2 2026, an estimated $619K.
  • Boston Scientific made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #782 holding.
  • Summit Securities Group first reported a position in Boston Scientific in Q4 2018 and has held it in 11 quarters since.
  • Summit Securities Group's Boston Scientific position peaked at $737K in Q1 2026.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.